Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Olfactory deficits and cardiac 123I-MIBG in Parkinson's disease related to the LRRK2 R1441G and G2019S mutations.

Movement disorders : official journal of the Movement Disorder Society - 1 Sept 2011

Ruiz-Martínez Javier, Gorostidi Ana, Goyenechea Estibaliz, Alzualde Ainhoa, Poza Juan José, Rodríguez Francisco, Bergareche Alberto, Moreno Fermín, López de Munain Adolfo, Martí Massó José F

Abstract excerpt

It has been proposed that olfactory tests and metaiodobenzylguanidine cardiac scintigraphy may help diagnose idiopathic Parkinson's disease in the premotor phase. However, it is not clear what value these tests have in all patients with Parkinson's disease and, particularly, in those who carry mu...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cohort Studies
Share to Heart

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Leucine-Rich Repeat Serine-Threonine Protein Kinase-2

Share to Olfaction Disorders

Share to Parkinson Disease

Share to Protein Serine-Threonine Kinases

Share to Radiopharmaceuticals

Source

Identifiers

PMID: 21611983
DOI: 10.1002/mds.23773

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-21611983-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Olfactory deficits and cardiac 123I-MIBG in Parkinson's disease related to the LRRK2 R1441G and G2019S mutations.PMID 21611983Read ↗

123I-MIBG cardiac uptake and smell identification in parkinsonian patients with LRRK2 mutations.Semantic proximity Read ↗

Myocardial 123I-metaiodobenzylguanidine scintigraphy in patients with homozygous and heterozygous parkin mutations.Semantic proximity Read ↗

Association of Olfactory Performance With Motor Decline and Age at Onset in People With Parkinson Disease and the LRRK2 G2019S Variant.Semantic proximity Read ↗

Olfactory dysfunction in LRRK2 G2019S mutation carriers.Semantic proximity Read ↗

Myocardial 123metaiodobenzylguanidine uptake in genetic Parkinson's disease.Semantic proximity Read ↗

Olfaction and imaging biomarkers in premotor LRRK2 G2019S-associated Parkinson disease.Semantic proximity Read ↗

Olfactory identification in LRRK 2 G2019S mutation carriers: a relevant marker?Semantic proximity Read ↗

Olfactory dysfunction in sporadic Parkinson's Disease and LRRK2 carriers.Semantic proximity Read ↗

Non-motor symptoms and cardiac innervation in SYNJ1-related parkinsonism.Semantic proximity Read ↗

Cardiac sympathetic denervation in bradykinesia-dominant Parkinson's disease.Semantic proximity Read ↗

Assessment of Olfactory Function in MAPT-Associated Neurodegenerative Disease Reveals Odor-Identification Irreproducibility as a Non-Disease-Specific, General Characteristic of Olfactory Dysfunction.Semantic proximity Read ↗

Cardiac 123I-MIBG scintigraphy can assess the disease severity and phenotype of PD.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.